NEW White Paper - Companion Diagnostic Development: An Overview Primary Human Mast Cells are Now Available Discovery's Contribution to AR Microscopy Study Featured in Nature Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments NEW Video - Advancing Oligo Therapeutics: Gene Knockdown Studies in Human Hepatocytes
NEW White Paper - Companion Diagnostic Development: An Overview Primary Human Mast Cells are Now Available Discovery's Contribution to AR Microscopy Study Featured in Nature Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments NEW Video - Advancing Oligo Therapeutics: Gene Knockdown Studies in Human Hepatocytes
CONTACT US
DISCOVERY BIOSTORE™
DLS-Logo-FullColor-noTag (1)
DLS-Logo-FullColor-noTag (1)

World CB & CDx Boston 2025

Boston, MA
September 22, 2025 – September 25, 2025

Contact Us

Connect with Discovery during the 15th World CB & CDx Summit in Boston from September 22-25, 2025, at The Westin Boston Seaport District. More details to come!

About the Event: 

Returning for its 15th anniversary this September, the World Clinical Biomarkers & Companion Diagnostics Summit will unite 600+ industry leaders across biopharma, CDx development, testing labs, regulators, and payers to advance clinical biomarker strategies and accelerate drug-diagnostics to market for improved patient diagnosis, stratification, and monitoring. 

EVENT WEBSITE

Featured Presentation

Wednesday, September 24, 2025 | 1:30 p.m. – 1:10 p.m.
From Lab Developed Test to kitted IVD: A CDx Journey
Scott Reid, VP & Global Head of Companion Diagnostics, Discovery Life Sciences

Presentation Overview

  • We will present an overview of utilizing lab developed tests to get prototype assays deployed quickly and inexpensively to support early phase clinical studies
  • A case study demonstrating successful transition from lab developed test to kitted solution with an in vitro diagnostic partner will be summarized

Schedule a Meeting at World CB & CDx Boston 2025​​

BIOSPECIMENS

Viable Cells

Tissues

Matched Sets

Blood Products

Other Biofluids

CELL BIOLOGY SERVICES

Hematopoietic Assay Services

Additional Blood Cell-Based Assay Services

Specialty Lab SERVICES

Genomics Services

Proteomics Services

Molecular Pathology

Cell & Gene Therapy Starting Materials

IN VITRO ADMET

Gentest Products

Gentest Services

CONTACT US
BIOSTORE™
CAREERS

MARKETS WE SERVE

COMPANY

Copyright © 2025 Discovery Life Sciences. All rights reserved.

Designed & Developed by Altitude Marketing

Markets We Serve

Resources

Biospecimens

Cell Biology Services

Specialty Lab Services

Cell & Gene Therapy Starting Materials

In Vitro ADMET

About Us

Popular Keywords

Categories,Pages

No Record Found

View All Results
Quick Links
Back

Discovery BIOstore™

Viable Cells

Tissues

Tumoroids

Matched Sets

Blood Products

Other Biofluids

Back

Cell Biology Services

Hematopoietic CFC Assay Services

Other Blood Cell-Based Assay Services

Back

Technologies

Development and Clinical
Trial Solutions

Back

Gentest® Products

Gentest®ADMET
Research Services

Back

Our Mission

Discovery Partners

Diversity & Inclusion

Careers

Viable Cells

Dissociated Tissue (DTCs)

SpecimenSeq™ BMMCs & PBMCs

Tumoroids

Peripheral Blood Mononuclear Cells (PBMCs)

Immune Cell Subsets

Bone Marrow Mononuclear Cells (BMMCs)

Hepatocytes

SpecimenSeq™ DTCs

Mast Cells

Back

Tissues

FFPE Tissue

SpecimenSeq™ FFPE

Dissociated Tissue (DTCs)

SpecimenSeq™ FFPE + Plasma

Tumoroids

Flash Frozen + FFPE

Back

Matched Sets

FFPE Matched Sets

SpecimenSeq™ FFPE+Plasma​

Flash Frozen Tissues + FFPE​

DTCs Matched Sets

Back

Cell Biology Services

Single Cell Gene Expression

Spatial Gene Expression

In Vitro Cell Culture

Cell Dissociation

Back

Myeloid and Erythroid CFC Assays

Megakaryocytic CFC Assays

Blood Cancer CFC Assays

Metabolic Co-Culture CFC Assays

Back

Technologies

Genomics Services

RNA-Sequencing

Exome Sequencing

Single Cell and Spatial Sequencing

Whole Genome Sequencing

Epigenomic Sequencing

NGS Bioinformatics

Molecular Pathology Services

Immunohistochemistry

Multiplex Immunofluorescence

Hyperplex Immunofluorescence

In Situ Hybridization

Histology & Digital Pathology

Quantitative Gene Expression Analysis

Proteomics Services

Olink

Mass Spectrometry

Plasma Proteomics

Global Proteomics

Clinical Flow Cytometry Services

Back

Development and Clinical
Trial Solutions

Clinical Trial Testing services

Assay Development & Validation

Pre-Clinical & Translational Studies

Target Expression &
Prevalence Screening

Clinical Trial HLA Typing Services

IVDR

Post-Approval Services

Concordance Studies

Biomarker Academy Training

Back

Gentest® Products

Hepatocytes

Microsomes

Tissue Fractions

TransportoCells™

Supersomes®

Gentest Resources

Back

Gentest® ADME Research Services

Enzyme Induction Services

Enzyme Inhibition services

Transporter Interaction

Reaction Phenotyping

Back
Privacy Settings